Changzhou pharmaceutical factory has perfect chemical production capacity and enzyme screening, evolution and fermentation production capacity, and is skilled in the application of enzyme catalysis technology in API's production. Selective engineering enzymes have been successfully applied to the commercial production of several APIs and intermediates.
Changzhou pharmaceutical factory has complete biotransformation capability and integrate it into traditional chemical process we good at to provide a greener and environmentally friendly process, so as to ultimately reduce the cost and guarantee the security of supply chain for customers.

Changzhou pharmaceutical factory has been committed to the development of continuous production technology and its application in the pharmaceutical industry. At present, we have the ability of continuous chemical process R&D and skilled in transforming continuous flow production technology into workshop production.
Reaction types we can apply well include low-temperature reaction, high-temperature reaction, diazomethane reaction, nitration reaction, ozonation reaction, photochemical reaction, Grignard reagent preparation and application, catalytic hydrogenation reaction, Curtius rearrangement, gas participation in reaction, etc.

Changzhou pharmaceutical factory have rich experience in crystal form selection and development, and have successfully developed many new crystal forms and amorphous production processes of APIs.
We can provide customized crystal development services for customers, avoiding the risk of patent infringement and enabling customer’s drugs to be put on the market as soon as possible.

Changzhou pharmaceutical factory have a R&D team led by a postdoctoral chemist in the field of photocatalysis chemistry and perfect experimental facilities, and have rich experience in the development of photocatalysis reaction process.
We have applied photocatalysis technology to cycloaddition, rearrangement, isomerization, photooxidation reactions in the preparation of some APIs and intermediates.

Changzhou pharmaceutical factory has invested a lot of resources to establish and develop the R & D and production capacity of microwave reaction, aiming to improve the safety and efficiency in the drug manufacturing process, broaden the types of reactions, and provide more choices for designing the synthetic route of API.

Changzhou pharmaceutical factory has a high-level sustained and controlled release R&D team and production line, and has rich experience in the development of sustained and controlled release preparations such as osmotic pump, skeleton, membrane controlled and pellets. We have developed and registered a series of sustained and controlled release preparations.